Chi-yuan Hsu, MD, MSc


Dr. Chi-yuan Hsu is a nephrologist who cares for adults with kidney disease in both inpatient and outpatient settings.

Hsu's research investigates acute, chronic and end-stage renal disease, including strategies to improve outcomes for patients with these conditions. Questions that arise in the course of caring for patients have often motivated his research.

Hsu earned his medical degree from Harvard Medical School and a master's degree in clinical epidemiology from Harvard School of Public Health. He completed a residency in internal medicine at Beth Israel Hospital, followed by a fellowship in nephrology at Massachusetts General Hospital.

Hsu is a member of the American Society for Clinical Investigation, American Medical Association, American College of Physicians, American Society of Nephrology, National Kidney Foundation, International Society of Nephrology, Chinese American Society of Nephrology, Association of Specialty Professors and Renal Physicians Association. He is a fellow of the American College of Physicians and American Society of Nephrology, and has been voted a best doctor by San Francisco magazine, Marin Magazine and Castle Connolly, a consumer guide to preeminent U.S. health care. He is a professor at UCSF and the division chief of nephrology.


Nephrology and Hypertension Faculty Practice
400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143-0532
Phone: (415) 353-2507
Fax: (415) 353-2530

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Nephrology, American Board of Internal Medicine

Academic Title


More about Chi-yuan Hsu

Additional Languages



Harvard University School of Medicine 1993
Harvard School of Public Health, M.Sc., Clinical Epidemiology 1999


Boston's Beth Israel Hospital, Internal Medicine 1996


Massachusetts General Hospital, Nephrology 1998

Selected Research and Publications

  1. Lin MY, Cheng LJ, Chiu YW, Hsieh HM, Wu PH, Lin YT, Wang SL, Jian FX, Hsu CC, Yang SA, Lee HL, Hwang SJ. Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study. PLoS One. 2018; 13(6):e0198387.
  2. Wu CL, Chang CC, Kor CT, Yang TH, Chiu PF, Tarng DC, Hsu CC. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis. Clin J Am Soc Nephrol. 2018 May 07; 13(5):702-709.
  3. Guo JC, Lin CC, Huang TC, Huang PM, Kuo HY, Chang CH, Wang CC, Cheng JC, Yeh KH, Hsu CH, Lee JM. Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Anticancer Res. 2018 03; 38(3):1569-1577.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.